The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Overview of attention for article published in Trials, June 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 9 tweets from 9 users, with an upper bound of 5,829 followers.

The ProBio trial: molecular #biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate #cancer. @karolinskainst https://t.co/Io05iQgp0J https://t.co/px0vwQrlxl

RT @ProBioTrial: The @ProBioTrial - molecular #biomarkers for advancing personalized treatment decision in patients with metastatic castrat…

RT @ProBioTrial: The @ProBioTrial - molecular #biomarkers for advancing personalized treatment decision in patients with metastatic castrat…

RT @ProBioTrial: The @ProBioTrial - molecular #biomarkers for advancing personalized treatment decision in patients with metastatic castrat…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 5 additional tweets.